KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) Treasury Shares (2016 - 2025)

AbbVie (ABBV) has disclosed Treasury Shares for 13 consecutive years, with $9.1 billion as the latest value for Q4 2025.

  • Quarterly Treasury Shares rose 11.52% to $9.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.1 billion through Dec 2025, up 11.52% year-over-year, with the annual reading at $9.1 billion for FY2025, 11.52% up from the prior year.
  • Treasury Shares for Q4 2025 was $70.8 million at AbbVie, roughly flat from $70.8 million in the prior quarter.
  • The five-year high for Treasury Shares was $70.8 million in Q2 2025, with the low at $5.0 million in Q3 2021.
  • Average Treasury Shares over 5 years is $21.7 million, with a median of $9.0 million recorded in 2021.
  • Peak annual rise in Treasury Shares hit 54.34% in 2021, while the deepest fall reached 87.98% in 2021.
  • Over 5 years, Treasury Shares stood at $3.1 billion in 2021, then surged by 46.17% to $4.6 billion in 2022, then skyrocketed by 42.21% to $6.5 billion in 2023, then grew by 25.53% to $8.2 billion in 2024, then increased by 11.52% to $9.1 billion in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $9.1 billion, $9.1 billion, and $9.1 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.